Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly’s connected insulin solutions
COLUMBIA, Md. and INDIANAPOLIS, Feb. 25, 2021 /PRNewswire/ — Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Under the terms of…
Comments Off on
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly’s connected insulin solutions